Date published: 2026-4-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

GSK-3β substrate (negative control): sc-3115

0.0(0)
Write a reviewAsk a question

Datasheets
  • synthetic substrate for GSK-3β, 0.5 mg/0.1 ml
  • sequence: GPHRATPEARAAV (>97% pure by HPLC)
  • negative control K-3β, wherein the Ser 353 and Ser 357 sites are replaced with Ala residues
    Gene Editing Promo Banner

    QUICK LINKS

    The GSK-3β substrate (negative control) is an essential tool in molecular research, serving as a crucial reference in experiments involving glycogen synthase kinase-3 beta (GSK-3β) signaling pathways. Unlike active GSK-3β substrates, this negative control lacks the specific sequence motifs required for GSK-3β phosphorylation, rendering it non-responsive to the enzyme′s activity. By including the GSK-3β substrate (negative control) in experimental setups alongside active GSK-3β substrates, researchers can assess the specificity and validity of their findings. Widely utilized in biochemical and cell biology studies, this negative control compound aids in discerning genuine effects of GSK-3β modulation from non-specific effects. Moreover, its utilization facilitates the interpretation of experimental results, enabling researchers to distinguish specific GSK-3β-mediated effects from background noise. Continued use of the GSK-3β substrate (negative control) enhances the rigor and reproducibility of research investigating the role of GSK-3β in various physiological and pathological contexts, ultimately advancing our understanding of its function in cellular signaling networks.

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    GSK-3β substrate (negative control)

    sc-3115
    0.5 mg/0.1 ml
    $96.00